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ABSTRACT  
The present research work is based on the formulation and evaluation of topical gel of Ibuprofen where Carbopol 940 is used as the polymer. 
Gels were prepared by dispersing the polymers  in a mixture of water and glycerol with methyl paraben as the preservative and  the varying 
amount of ibuprofen, being kept under magnetic stirring until the homogeneous dispersion was formed. The dispersion was then neutralized 
and made viscous by the addition of triethanolamine. The Carbopol gels of Ibuprofen were found to be homogenous with good drug loading. 
The pH of all the gel formulations was found within the neutral pH range which is compatible with skin. And the viscosity of the formulations 
was found to be feasible for topical drug delivery. The drug content of the three formulations was found in the range of 87.56% to 90.45% 
which shows efficient drug loading. Results of In vitro drug release study showed that F5 formulation has better diffusion of drug through egg 
membrane and hence further permeation studies were carried out through rat epidermis. The compatibility study showed that the major peaks 
in FTIR spectra of the pure drug were found to be intact in their physical mixture. Hence there is no interaction between drug and Carbopol in 
their physical mixture. Carbopol can be effectively used as the polymer for topical gel preparation. And F5 formulation containing 0.5 % w/w 
Carbopol 940 may be effectively used as topical transdermal delivery for Ibuprofen. 
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INTRODUCTION 
The dosage forms, whether a tablet, an injection or a patch, 
to deliver the right amount of medicine at the right time to 
the right target site becomes complicated if each medicine is 
to be delivered in an optimal and preferred manner to the 
individual patient. The medication may not be absorbed if it 
is released too slowly or too rapidly, or the patient may 
suffer adverse effects and as because it’s desired effects may 
not last as long as it needed. These limitations are being 
overcome by transdermal drug delivery systems as they 
achieve several advantages over conventional dosage forms. 
Transdermal drug delivery is a route which can deliver 
medicines via the skin portal to systemic circulation at a 
predetermined rate and maintain clinically effective 
concentrations over a prolonged period of time. Transdermal 
route of drug administration avoids discomfort associated 
with parental therapy and improves patient compliance. This 
route of administration also eliminates the side effects that 
are caused by the conventional drug forms and also provide 
controlled release of drugs directly into the bloodstream 
through the intact skin. Transdermal delivery can provide a 
number of advantages over the conventional method of drug 
administration like-enhanced efficacy, increased safety, 
greater convenience, improved patient compliance. The 
various advantages of Transdermal Drug Delivery System are 
– It avoids significant presystemic metabolism and therefore 
the need for the daily requirement is low. It reduces inter 
and intrapatient variability. Drug levels can be maintained in 
the systemic circulation within the therapeutic limit. The 
duration of drug action following a single administration of 
the drug can be extended and the frequency of dosing is 
reduced. It improves patient compliance and acceptability of 
the drug therapy. Drug input can be terminated simply by 
removal of the patch.[1,2,3] Taking into account several 
advantages associated with Transdermal drug delivery route, 
we have decided to utilize ‘Ibuprofen’, which is a non-
steroidal anti-inflammatory drug (NSAID) used for pain 
relief, fever reduction, and against swelling.[4] Carbopol 940 
is used as the polymer, which is ideal for applications such as 
clear gels, hydroalcoholic gels, creams.[5,6] 
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Objective 
The objective is to prepare transdermal topical gel of 
Ibuprofen using Carbopol 940 which can be effectively used 
for transdermal topical delivery. 
MATERIALS AND METHODS 
Materials 
Chemicals 
Ibuprofen (Hi Media, Mumbai, India), Triethanolamine 
(Merck ,Mumbai, India), Methyl Paraben (Hi Media, Mumbai, 
India), Glycerol (Merck, Mumbai, India), Carbopol (Balaji 
Drugs, India) were procured and used in the investigation.All 
other reagents used were of analytical grade. 
Animals 
Wistar albino rats (male) were used of 250-500 gm were 
used which were supplied by animal house of Girijananda 
Chowdhury Institute of Pharmaceutical Science which were 
kept under proper laboratory condition. The animals were 
received only after the proposed study was approved by the 
Institute Animal Ethics committee bearing the number 
GIPS/IAEC/BPH/2013/4. 
Preparation of standard curve: 
0.1mg of ibuprofen was weighed accurately and was 
dissolved in 10 ml of ethanol and the volume was adjusted to 
100 ml by pH 7.4 and various dilutions were made to obtain 
concentration 2-50 mcg/ml and the absorbance was 
measured in the Ultra Violet (UV)  Spectrophotometer at 
λmax 267 nm, and a standard curve was obtained by plotting 
concentration against the absorbance.[7] 
Preparation of transdermal gel: 
Gels were prepared by dispersing the polymers (Carbopol 
940) in a mixture of water and glycerol with methylparaben 
as the preservative and the varying amount of ibuprofen, 
being kept under magnetic stirring until the homogeneous 
dispersion was formed. The dispersion was then neutralized 
and made viscous by the addition of triethanolamine [8,9] as 
shown in Table 1. 
 
                                             
Table 1: Gel Formulation 
Formulation 
Code 
Drug (mg) Carbopol 940 
(gm) 
Methyl Paraben 
(mg) 
Glycerin (ml) Triethanolamine 
(ml) 
F1 10 1 200 1 0.1 
F2 10 0.5 200 1 0.1 
F3 10 0.75 200 1 0.1 
F4 20 0.5 200 1 0.1 
F5 50 0.5 200 1 0.1 
 
 
Preparation of pH 7.4: 
2.38 gm of Disodium Hydrogen Phosphate, 0.19 gm of 
Potassium Dihydrogen Phosphate and 8 gm of Sodium 
Chloride were weighed accurately and it was diluted up to 
1000 ml.[10] 
Evaluation Of Transdermal Gel: 
Determination of gel pH  
The pH of the three gel formulations was determined by 
using digital pH meter after calibration with standard buffer 
pH 4.0, and 9.0 by inserting the electrode system into the 
gel.[11] 
Spreadability  
One of the criteria for a gel to meet the ideal quantities is 
that it should possess good spreadability. It is the term 
expressed to denote the extent of the area to which gel 
readily spreads on application to the skin or affected part. 
The therapeutic efficacy of a formulation also depends upon 
its spreading value. Spreadability is expressed in terms of 
time in seconds taken by two slides to slip off from the gel 
and placed in between the slides under the direction of 
certain load. Lesser the time is taken for separation of two 
slides, better the spreadability. It is calculated by using the 
formula: S = M. L / T Where M = weight tied to upper slide, L 
= length of the glass slide, T = time taken to separate the 
slides.[12] 
Viscosity  
Brookfield (DV-E Viscometer) attached with spindle was 
used for determination of viscosity. Gels were filled in jar 
and spindle was lowered perpendicularly taking care that 
spindle does not touch the bottom of the jar. The spindle 
number 63 was rotated in the gel at 20 rpm. At each speed, 
the corresponding dial reading was noted. The reverse 
reading was also noted and average was taken for these two 
readings. The viscosity of the gel was obtained by the 
multiplication of the dial readings with the factors given in 
the Brookfield viscometer catalogs. The spindle size used is 
64.[13]  
Drug content 
1 gm of the prepared gel was weighed accurately and 
dissolved in 10 ml of ethanol and was then filtered.1ml of 
the filtrate was taken and was diluted up to 100 ml by pH 7.4 
and was observed in the Ultra violet (UV) 
spectrophotometer at 267 nm.[14,15,16]  
In-vitro drug release/permeation study 
The drug release/ permeation studies of the prepared gels 
were carried out in Keshary-Chien diffusion cell for studying 
the drug release from the gels through an egg membrane. Gel 
sample (0.5g) was placed on the membrane and the diffusion 
studies were carried out at 37 ± 0.5°C using 250 ml of 
phosphate buffer (pH 7.4) as the receptor medium. Five 
milliliters of each sample was withdrawn periodically at 15, 
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30, 60, 120 and 240 minutes. Each sample was replaced with 
equal volume of fresh receptor medium. Then the samples 
were analyzed by UV spectrophotometer at 267 nm for the 
drug content by using phosphate buffer as blank.[17,18,19]   
Compatibility study 
The Fourier- transform infrared spectroscopy (FTIR) spectra 
of pure drug, Carbopol, and physical mixture of drug 
Carbopol (1:3) were taken and studied for any interaction 
using FTIR, Bruker Alpha instrument.[20,21,22] 
RESULT AND DISCUSSION 
Standard calibration curve of Ibuprofen:  
The standard calibration curve of Ibuprofen was plotted in 
phosphate buffer, pH 7.4. The scanning of standard solution 
has resulted maximum absorption peak at the wavelength of 
267 nm. It was observed that Beer-Lambert‘s law was 
obeyed within the concentration range of 2.0 μg/ml to 50.0 
μg/ml, in phosphate buffer, pH 7.4 as shown in Table 2 and 
Fig. 1. 
 
Fig 1: Standard Curve of Ibuprofen 
PH of Ibuprofen Gel: 
The pH of the gel formulations was found as 7.0 to 7.5 and a 
comparison study was done with a standard gel as shown in 
Table 2. 
Table 2: pH of Gel Formulation 
Formulation pH (mean±SD) 
F1 7.2±0.18 
F2 7.5±0.20 
F3 7.0±0.15 
F4 7.3±0.07 
F5 7.2±0.18 
Nurofen (Boots Healthcare) 7.4±0.14 
 
 
Drug spreadability study: 
The spreadability of the different gel formulations after 1 
min. was determined and was compared with a standard gel 
and noted in Table 3. 
Table 3: Spreadability of Gel Formulation 
Formulation Spreadibility (mean±SD) 
F1 19.79 
F2 22.5 
F3 21.25 
F4 22.29 
F5 22.08 
Nurofen (Boots Healthcare) 21 
 
Viscosity: 
The viscosity of the gel formulations was found between 
15900 to 23230 cps. The results are shown in Table 4. 
Table 4: Viscosity of Gel Formulation (20 rpm) 
Formulation Viscosity (mean±SD) 
F1 20800±4336.828 
F2 23230±4984.532 
F3 27700±5981.081 
F4 15900±2969.848 
F5 20100±4984.532 
 
Drug Content: 
The drug content of the gel formulations was found in the 
range of 87.56 to 90.45 % which shows efficient drug 
loading. The results are shown in Table-5. 
Table 5: Drug Content of Different Formulation 
Formulation Drug Content (mean±SD)  
F1 87.56±1.11 
F2 89.67±0.85 
F3 88.44±1.02 
F4 90.45±0.94 
F5 89.12±0.85 
 
In-vitro drug release/permeation study: 
In-vitro drug release of all the formulation through egg 
membrane is shown in Fig-2. 
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Fig 2: RELEASE PROFILE OF IBUPROFEN FROM GELS THROUGH EGG MEMBRANE Formulation F5 shows the highest release 
across the egg membrane chosen for permeation across rat epidermis. The result of permeation of transdermal gel across rat 
epidermis is shown in Fig 3. 
 
Fig 3: Permeation Profile oF Ibuprofen from Transdermal Gel through Rat Epidermis 
Drug compatibility study: 
Fourier- transform infrared spectroscopy (FTIR) spectra of 
pure drug, carbopol 940 and 1:3 ratio of the physical mixture 
of drug- carbopol 940 is presented in Fig-7 to 9 respectively. 
All the major peaks such as of alkenes i.e. C-H (stretching) at 
2988.29, 2949.21, 2867.97, carbonyl group i.e. C=O 
(stretching) at 1707.22, aromatic C=C (stretching) at 
1504.04, alkyl halide groups i.e. C=F (stretching) at 1454.85, 
1266.87, 1225.51, 1179.08, are retained in the physical 
mixture. Thus it indicates that the drug is compatible with 
the polymer used in the formulations as shown in Fig.4, Fig.5, 
Fig.6.
 
 
Fig-4: FTIR Spectra of Pure Drug (Ibuprofen) 
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Fig-5: FTIR Spectra of Carbopol 940 
 
Fig-6: FTIR Spectra of Ibuprofen:Carbopol 940 
 
 
DISCUSSION  
The Carbopol gels of Ibuprofen were found to be 
homogenous with good drug loading. The pH of all the gel 
formulations was found within the neutral pH range which is 
compatible with skin. And the viscosity of all formulations 
was found to be feasible for topical drug delivery. The drug 
content of the three formulations was found in the range of 
87.56 to 90.45% which shows efficient drug loading. Results 
of in-vitro drug release study showed that F5 formulation 
has better diffusion of drug through egg membrane and 
hence further permeation studies were carried out through 
rat epidermis. The compatibility study showed that the 
major peaks in Fourier- transform infrared spectroscopy 
(FTIR) spectra of the pure drug were found to be intact in 
their physical mixture. Hence there is no interaction 
between drug and Carbopol in their physical mixture.  
CONCLUSION 
It can be concluded that Carbopol can be effectively used as 
the polymer for topical gel preparation. And F5 formulation 
containing 0.5 % w/w Carbopol 940 may be effectively used 
as topical transdermal delivery for Ibuprofen. 
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